GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » ACI Formulations Ltd (DHA:ACIFORMULA) » Definitions » EV-to-EBIT

ACI Formulations (DHA:ACIFORMULA) EV-to-EBIT : 14.52 (As of May. 13, 2024)


View and export this data going back to 2008. Start your Free Trial

What is ACI Formulations EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ACI Formulations's Enterprise Value is BDT9,002 Mil. ACI Formulations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was BDT620 Mil. Therefore, ACI Formulations's EV-to-EBIT for today is 14.52.

The historical rank and industry rank for ACI Formulations's EV-to-EBIT or its related term are showing as below:

DHA:ACIFORMULA' s EV-to-EBIT Range Over the Past 10 Years
Min: 12.34   Med: 20.52   Max: 36.46
Current: 14.52

During the past 13 years, the highest EV-to-EBIT of ACI Formulations was 36.46. The lowest was 12.34. And the median was 20.52.

DHA:ACIFORMULA's EV-to-EBIT is ranked worse than
50.82% of 183 companies
in the Agriculture industry
Industry Median: 13.94 vs DHA:ACIFORMULA: 14.52

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. ACI Formulations's Enterprise Value for the quarter that ended in Dec. 2023 was BDT9,996 Mil. ACI Formulations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was BDT620 Mil. ACI Formulations's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.20%.


ACI Formulations EV-to-EBIT Historical Data

The historical data trend for ACI Formulations's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACI Formulations EV-to-EBIT Chart

ACI Formulations Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.43 18.42 19.39 21.53 17.47

ACI Formulations Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.41 19.75 17.47 16.54 16.12

Competitive Comparison of ACI Formulations's EV-to-EBIT

For the Agricultural Inputs subindustry, ACI Formulations's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACI Formulations's EV-to-EBIT Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, ACI Formulations's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where ACI Formulations's EV-to-EBIT falls into.



ACI Formulations EV-to-EBIT Calculation

ACI Formulations's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=9002.423/620.149
=14.52

ACI Formulations's current Enterprise Value is BDT9,002 Mil.
ACI Formulations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT620 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACI Formulations  (DHA:ACIFORMULA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

ACI Formulations's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=620.149/9996.419
=6.20 %

ACI Formulations's Enterprise Value for the quarter that ended in Dec. 2023 was BDT9,996 Mil.
ACI Formulations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT620 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACI Formulations EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of ACI Formulations's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


ACI Formulations (DHA:ACIFORMULA) Business Description

Traded in Other Exchanges
N/A
Address
ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.

ACI Formulations (DHA:ACIFORMULA) Headlines

No Headlines